Tert-butyl 4-[[3-(7-fluoro-2-methylindazol-5-yl)-4-oxoquinazolin-6-yl]-methylamino]piperidine-1-carboxylate
C27H31FN6O3 — CID 156888186
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[[3-(7-fluoro-2-methylindazol-5-yl)-4-oxoquinazolin-6-yl]-methylamino]piperidine-1-carboxylate
Tert-butyl 4-[[3-(7-fluoro-2-methylindazol-5-yl)-4-oxoquinazolin-6-yl]-methylamino]piperidine-1-carboxylate (PubChem CID 156888186) has the molecular formula C27H31FN6O3 and a molecular weight of 506.58 g/mol. Its IUPAC name is tert-butyl 4-[[3-(7-fluoro-2-methylindazol-5-yl)-4-oxoquinazolin-6-yl]-methylamino]piperidine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-[[3-(7-fluoro-2-methylindazol-5-yl)-4-oxoquinazolin-6-yl]-methylamino]piperidine-1-carboxylate |
|---|---|
| PubChem CID | 156888186 |
| Molecular Formula | C27H31FN6O3 |
| Molecular Weight | 506.58 g/mol |
| Exact Mass | 506.24 |
| IUPAC Name | tert-butyl 4-[[3-(7-fluoro-2-methylindazol-5-yl)-4-oxoquinazolin-6-yl]-methylamino]piperidine-1-carboxylate |
| SMILES | CN(c1ccc2ncn(-c3cc(F)c4nn(C)cc4c3)c(=O)c2c1)C1CCN(C(=O)OC(C)(C)C)CC1 |
| InChI | InChI=1S/C27H31FN6O3/c1-27(2,3)37-26(36)33-10-8-18(9-11-33)32(5)19-6-7-23-21(13-19)25(35)34(16-29-23)20-12-17-15-31(4)30-24(17)22(28)14-20/h6-7,12-16,18H,8-11H2,1-5H3 |
| InChIKey | YPXSUVAGZIOOQA-UHFFFAOYSA-N |
| XLogP | 4.25 |
| TPSA | 85.49 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 506.58 |
| LogP ≤ 5 | 4.25 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156888186 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.